BR112021016960A2 - Processo para a preparação de uma imidazoquinolina substituída - Google Patents

Processo para a preparação de uma imidazoquinolina substituída

Info

Publication number
BR112021016960A2
BR112021016960A2 BR112021016960A BR112021016960A BR112021016960A2 BR 112021016960 A2 BR112021016960 A2 BR 112021016960A2 BR 112021016960 A BR112021016960 A BR 112021016960A BR 112021016960 A BR112021016960 A BR 112021016960A BR 112021016960 A2 BR112021016960 A2 BR 112021016960A2
Authority
BR
Brazil
Prior art keywords
preparation
substituted imidazoquinoline
quinolin
imidazo
pyran
Prior art date
Application number
BR112021016960A
Other languages
English (en)
Inventor
Christophe Henry
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of BR112021016960A2 publication Critical patent/BR112021016960A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/46Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

processo para a preparação de uma imidazoquinolina substituída. a presente invenção se refere a um processo para sintetizar n-(4-(4-amino-2-(2 metoxietil)-1h-imidazo [4,5- c] quinolin-1-il)butil)-n-(tetrahidro-2h-piran-4-il) acetamida, um derivado de imidazoquinolina útil como agonista do receptor do tipo toll, em particular, como agonista de tlr7, que promove a indução de certas citocinas. além disso, a presente invenção também fornece intermediários úteis na síntese de n-(4-(4-amino-2-(2- metoxietil)-1h-imidazo[4,5-c]quinolin-1-il)butil)-n-(tetra hidro-2h-piran-4-il) acetamida.
BR112021016960A 2019-03-07 2020-03-06 Processo para a preparação de uma imidazoquinolina substituída BR112021016960A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2019055793 2019-03-07
PCT/EP2020/056047 WO2020178434A1 (en) 2019-03-07 2020-03-06 Process for the preparation of a substituted imidazoquinoline

Publications (1)

Publication Number Publication Date
BR112021016960A2 true BR112021016960A2 (pt) 2021-11-23

Family

ID=69723965

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021016960A BR112021016960A2 (pt) 2019-03-07 2020-03-06 Processo para a preparação de uma imidazoquinolina substituída

Country Status (16)

Country Link
US (1) US20220144822A1 (pt)
EP (1) EP3935047B1 (pt)
JP (1) JP2022525023A (pt)
KR (1) KR20210136033A (pt)
CN (1) CN113518775A (pt)
AU (1) AU2020231822A1 (pt)
BR (1) BR112021016960A2 (pt)
CA (1) CA3132229A1 (pt)
CL (1) CL2021002322A1 (pt)
CO (1) CO2021011258A2 (pt)
CU (1) CU24679B1 (pt)
DK (1) DK3935047T3 (pt)
IL (1) IL286054A (pt)
MX (1) MX2021010669A (pt)
SG (1) SG11202108752YA (pt)
WO (1) WO2020178434A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023083439A1 (en) * 2021-11-09 2023-05-19 BioNTech SE Tlr7 agonist and combinations for cancer treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
PE20040945A1 (es) * 2003-02-05 2004-12-14 Warner Lambert Co Preparacion de quinazolinas substituidas
EP1686992A4 (en) 2003-11-25 2009-11-04 3M Innovative Properties Co HYDROXYLAMINE, AND IMIDAZOQUINOLEINS, AND IMIDAZOPYRIDINES AND IMIDAZONAPHTYRIDINE SUBSTITUTED WITH OXIME
MX344330B (es) * 2008-03-24 2016-12-13 4Sc Ag Imidazoquinolinas substituidas novedosas.
US8735386B2 (en) * 2010-07-23 2014-05-27 Boehringer Ingelheim International Gmbh Aminopyrazoloquinazolines
UA113280C2 (xx) * 2010-11-11 2017-01-10 АМІНОСПИРТЗАМІЩЕНІ ПОХІДНІ 2,3-ДИГІДРОІМІДАЗО$1,2-c]ХІНАЗОЛІНУ, ПРИДАТНІ ДЛЯ ЛІКУВАННЯ ГІПЕРПРОЛІФЕРАТИВНИХ ПОРУШЕНЬ І ЗАХВОРЮВАНЬ, ПОВ'ЯЗАНИХ З АНГІОГЕНЕЗОМ
AU2018329152B2 (en) * 2017-09-06 2024-02-15 BioNTech SE Substituted imidazoquinolines as agonists of TLR7
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES

Also Published As

Publication number Publication date
DK3935047T3 (da) 2024-09-09
CU24679B1 (es) 2023-09-07
SG11202108752YA (en) 2021-09-29
EP3935047A1 (en) 2022-01-12
US20220144822A1 (en) 2022-05-12
EP3935047B1 (en) 2024-08-07
WO2020178434A1 (en) 2020-09-10
JP2022525023A (ja) 2022-05-11
CL2021002322A1 (es) 2022-05-13
IL286054A (en) 2021-10-31
CO2021011258A2 (es) 2021-09-09
KR20210136033A (ko) 2021-11-16
CU20210071A7 (es) 2022-04-07
AU2020231822A1 (en) 2021-08-26
MX2021010669A (es) 2021-09-28
CN113518775A (zh) 2021-10-19
CA3132229A1 (en) 2020-09-10

Similar Documents

Publication Publication Date Title
CL2014003181A1 (es) Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas.
AR081577A1 (es) Derivados de aminopirimidina como moduladores de la lrrk2
AR085149A1 (es) Moduladores del receptor de glucagon
IN2014CN00961A (pt)
PE20151981A1 (es) Pontenciador de inhibidores del homologo de zeste
DOP2011000076A (es) Derivados de heteroaril amidas y su uso como activadores de glucoquinasa
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
CO6290683A2 (es) Compuestos de pirido imidazolinas heterociclicas y sus composiciones como inhibidores de c-met
ECSP13012958A (es) Inhibidores de benzodioxano de la producción de leucotrieno.
UY32863A (es) COMPUESTOS DE HEXAHIDROOXAZINOPTERINA PARA USO COMO INHIBIDORES DE mTOR
BR112017017349A2 (pt) composto, composição, método para tratar um distúrbio
SV2010003677A (es) Inhibidores de desacetilasas b a base de hidroxamato
AR082111A1 (es) Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas
CR20140553A (es) Compuestos de fenoxietil piperidina
CU24365B1 (es) Derivados de oxazolidin-2-ona-pirimidina
BR112021016960A2 (pt) Processo para a preparação de uma imidazoquinolina substituída
PH12015500795B1 (en) N-(2-(cyclic amine)ethyl)benzamide derivatives as p2x7 inhibitors
ECSP11010807A (es) Sales de los compuestos del inhibidor de vih
BR112015028801A2 (pt) copolímero por blocos e processo para a preparação do mesmo
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
BR112013003121A2 (pt) moduladores de trpv3
CY1115983T1 (el) Συνθεση toy aliskiren
BR112016018418A2 (pt) Composto, uso do mesmo, e composição farmacêutica
BR112013031334A2 (pt) método para preparar zeólitos do tipo lta utilizando um agente de dirigir estrutura novo
MX2022007916A (es) Conjugados que experimentan rearreglos intramoleculares.